Up next

Autoplay

Margaret Moline, PhD: Next-Morning Residual Effects of Lemborexant in Insomnia

2 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

At the 2019 American Academy of Neurology’s (AAN) Annual Meeting in Philadelphia, Pennsylvania, the results were presented from 3 randomized, double-blind, placebo-controlled studies that evaluated lemborexant 5 mg and 10 mg in healthy volunteers and subjects with insomnia to assess the potential for next-morning residual effects.

Read more: http://neurologylive.com/confe....rences/aan-2019/marg

Show more
0 Comments sort Sort By

Up next

Autoplay